Drug approvals: '08 in review. Olopatadine hydrochloride (Patanase) nasal spray.
Laustsen
Gary
G
Oregon Health and Science University, Portland, Ore., USA.
Carrillo
Fernando
F
Johnson
Jessica
J
Smith
Cynthia
C
D000280:Administration, Inhalation; D018926:Anti-Allergic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D003990:Dibenzoxepins / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D000069605:Olopatadine Hydrochloride; D006255:Rhinitis, Allergic, Seasonal / Q000188:drug therapy*
D018926:Anti-Allergic Agents; D003990:Dibenzoxepins; D000069605:Olopatadine Hydrochloride